Streamlyne modules are now available for IRB submissions and Conflict of Interest (COI) functions.
PDF forms will no longer be accepted for IRB submissions, which are due in Streamlyne at least 10 business days ahead of the posted meeting date.
Accessing Streamlyne
To access Streamlyne for IRB, click here.
Bookmark the Streamlyne URL: https://research.njit.streamlyne.org/
To login, use your NJIT UCID and password for NJIT Highlander Pipeline.
- Username: UCID
- Password: The same password to log into NJIT Pipeline
Streamlyne Training Materials
Various user support materials such as pre-recorded video, downloadable manuals and live training sessions are available for Streamlyne.
Pre-Recorded Training Videos
- Intro to Streamlyne (General)
- For Researchers: Intro to Streamlyne for IRB
- For Researchers: IRB Research Modification Application in Streamlyne
- For Researchers: Approving an IRB submission for Research Team Member
Streamlyne Web-Based Training Guide
- Web-Based Training: This online manual provides a step-by-step guide on using the modules in NJIT's Streamlyne System.
Streamlyne User Manuals (PDF)
- Streamlyne for IRB User Manual - This manual provides specific Streamlyne information for researchers requiring IRB review.
- Streamlyne New User Manual - Common Elements - This manual provides a reference to all the common elements of Streamlyne Research. This user manual is a good document to review each module’s functionality.
For IRB meeting schedules and deadlines click Here.
For IRB submission information and protocols click Here.
Questions related to Streamlyne software should be directed to the college/school representative:
John McCarthy, NCE Director of Research
(973) 596-3247; john.p.mccarthy@njit.edu
Cristo Leon, CSLA Director of Research
(973) 596-6426; cristo.e.yanezleon@njit.edu
Streamlyne point of contacts in the Office of Research:
Jesus Novoa, Senior Director, Pre-Award Services
973-642-4074; jesus.novoa@njit.edu
Theresa Walton MPA, Director of Sponsored Research Administration
973-642-7322, theresa.walton@njit.edu
Conflict of Interest (COI)
The term “conflict of interest (COI) in research” refers to situations where reasonable observers would believe that an investigator’s outside financial interest/s or obligation/s have the potential to inappropriately influence his/her judgment or actions in designing or conducting or reporting research or cause harm to human subjects participating in a research project. Such situations could also affect how staff are hired and how materials are procured. Similarly, “conflict of commitment in research” refers to situations where the external activities, either paid or unpaid, interfere with an investigator's primary research obligation and commitment to the university. Both occur when university members are in a position to derive personal benefit from actions or decisions made in their official capacity. Conflict of interest/commitment situations are inevitable because NJIT community members often interact in their private consulting/public service capacities with industry, government, community groups, and professional organizations. Being in this situation is not unethical, but not recognizing and not reporting them is, and this could tarnish the reputation of the researcher, his/her department, the institution, and also result in fines and loss of funding/employment. To prevent actual conflicts of interest and commitment as well as to avoid any perceived conflicts, all NJIT researchers must disclose their external professional activities and any financial interests in entities that they or their immediate family members may have that are related to their institutional responsibilities. Additionally, NJIT researchers are not allowed to hire or directly supervise relatives, including but not limited to spouses, parents, children, siblings, in-laws, or any other family members, in order to uphold objectivity and prevent nepotism in the workplace.
Federal regulations require any investigator applying for or receiving funding from the Public Health Service (PHS) (including the National Institutes of Health and the Centers for Disease Control and Prevention), sponsors adopting the PHS regulations, or the National Science Foundation (NSF) must submit a financial conflict of interest (COI) disclosure form at least once annually. NJIT also requires the completion of this information each time a research proposal is submitted for external funding. Additionally, NJIT researchers who are responsible for the design, conduct, or reporting of NIH funded research are required to take COI training at least every four years.
All researchers have an obligation to become familiar with, and abide by, the provisions of NJIT Financial Conflicts of Commitment and Interest (FCOI) on Sponsored Research Projects policy.
Reporting Conflict of Interest
The Office of Research is committed to ensuring that the personal interest/s of all NJIT researchers do not unduly influence his/her primary obligations to science, sponsors, university, colleagues or students. The purpose of the project specific and annual disclosure and certification processes are to confirm that the Office of Research has a complete, accurate, and up-to-date account of all NJIT researcher’s reportable outside activities and/or financial interests. As part of the disclosure process, researchers must certify that they are in compliance with all applicable NJIT policies and procedures. All NJIT researchers must complete an Annual Disclosure and Certification, and are also required to disclose, within 30 days of any change to their outside professional activities and interests.
The following activities are examples of potential conflict of interest situations:
- Accepting gratuities or favors (including equipment gifts or loans) from companies sponsoring your research or doing business with the University or that makes product/s that you are researching or developing;
- Accepting excessive honoraria for lectures at companies/entities that have an interest in your scientific or scholarly expertise and that also have the potential to benefit financially from your research;
- Working for or conducting any kind of research (including assigning your students) for a company/entity in which you have equity ownership or that has an interest in your research or that seeks to patent and license your invention;
- Assigning a textbook or text for which you receive royalties as “required reading” for a course;
- Representing the University for the purchase of materials/equipments from a company/entity in which you and your immediate family members have a financial interest or influencing NJIT business dealing with such company/entity in any way;
- Providing privileged information developed at NJIT to a company/entity in which you and your immediate family members have a financial interest;
- Accepting gifts from students/fellows who work on your research project and whom you must evaluate;
- Providing or receiving financial bonuses for recruiting a targeted number of research subjects;
- Holding any official or membership position on a board or committee of an company/entity that supports your research at NJIT or having any equity interests and/or stock options in that company/entity;
- Receiving royalties or other licensing proceeds from intellectual property that you invented at NJIT;
- Entering into a Materials Transfer Agreement or Human Tissue Agreement (MTA/HTA) to provide materials used in your research to an external company/entity; and
- Accepting a publication restriction condition in a research contract or imposing restrictions on disclosure of research findings and the actions of students/trainees at the request of a sponsor or a company/entity that has the potential to benefit from your research.
If a situation raising questions of conflict of interest arises, a researcher should discuss the situation with his or her department Chair or lab/division head or with the assistant director for research compliance and integrity or the executive director of sponsored research at the Office of Research.
All COI disclosures must be submitted via Streamlyne. For Streamlyne COI training and access information, go here.
While most disclosures of conflict of financial interests and conflict of commitment will be deemed de minimus or not significant in terms of potential effects on the individual’s ability to perform his or her NJIT duties without any undue influence, financial interests and commitments above thresholds will automatically be deemed significant and will require closer scrutiny and possible management, mitigation, and/or elimination.
Significant Financial Interests
Financial interest means anything of monetary value, including but not limited to compensation, equity, gifts, and intellectual property of an investigator or the immediate family member of an investigator, whether or not the value is readily ascertainable. It refers to financial interests related to the institutional responsibilities of an investigator and becomes "significant" if it meets ANY of the following conditions:
- All income from a publicly-traded entity received during the 12 months prior to disclosure plus the value of any equity interest in the entity as of the date of an annual disclosure, when combined, exceeds $10,000 or represents more than 5% ownership interest in any single entity. Examples of income include consulting fees, honoraria, or paid authorship. Equity interest includes any stock, stock option, or other ownership interest;
- ANY equity interest held in a non-publicly traded entity, or more than $10,000 in income from a non-publicly traded entity received during the 12 months prior to disclosure; or
- Income from intellectual property rights and interests received from an entity other than NJIT that exceeds $10,000 during the 12 months prior to disclosure.
If NJIT determines that a conflict of interest situation could unduly influence the research, the conflict will either be managed or mitigated or eliminated according to a management plan provided to the researcher by the Office of Research. Other administrative actions, such as embedding a financial interest disclosure in the publication and public talks to allow the audience to form their own opinions may be required. Some common strategies for managing, mitigating, or eliminating conflicts also include:
- Training on conflicts of interest and commitment for all involved researchers
- Monitoring and oversight of the research activity by an impartial third-party
- Modifying research design to either remove the conflicted researcher from participation in all or a portion of the research
- Divestiture of significant financial interests
- Prohibiting unacceptable levels of commitment/private interests
- Creating, implementing, and enforcing effective conflict of interest management plans
- Instituting a process to review the outcome or product produced by the researcher/s and the research by non-conflicted experts
US Public Health Service (PHS)
Please note that the U.S. Public Health Service (PHS) and its agencies define a "significant" financial interest (SFI) at a lower level than do other federal agencies, such as the National Science Foundation, and the university’s longstanding level of $10,000 described above.
Specifically, if you have worked on PHS funded research in the past year, or expect to work on PHS-funded projects this year, a financial interest becomes “significant” if it meets ANY of the following conditions:
- All income from a publicly-traded entity received during the 12 months prior to disclosure plus the value of any equity interest in the entity as of the date of an annual disclosure, when combined, exceeds $5,000. Examples of income include consulting fees, honoraria, or paid authorship. Equity interest includes any stock, stock option, or other ownership interest;
- ANY equity interest held in a non-publicly traded entity, or more than $5,000 in income from a non-publicly traded entity received during the 12 months prior to disclosure; or
- Income from intellectual property rights and interests received from an entity other than NJIT that exceeded $5,000 during the 12 months prior to disclosure.
PHS agencies include the National Institutes of Health (NIH), Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), Indian Health Service (IHS), Health Resources and Services Administration (HRSA), Substance Abuse and Mental Health Services Administration (SAMHSA), Agency for Healthcare Research and Quality (AHRQ), Centers for Medicare & Medicaid Services (CMS), Administration for Children and Families (ACF), or Administration on Aging (AOA).
If NJIT makes a determination that PHS agency funded investigators have a Financial Conflict of Interest, it will implement a management plan and report it (along with the management plan) to the PHS funding agency within 60 days.
NJIT is also required to make information regarding Financial Conflict of Interest reported to PHS accessible to the public upon PHS request.
Federal regulations and university policy do not require you to disclose the following types of financial interests:
- Reimbursement or payment of travel paid by NJIT, or covered by a sponsored program agreement managed through the Office of Research;
- Royalties received from NJIT for intellectual property owned by the university;
- Royalties resulting from traditional academic publishing activities such as the publication of text books or other educational materials;
- Any salary or other remuneration paid to you by NJIT.
Faculty, staff, and students are required to disclose the occurrence of any reimbursed or sponsored travel paid for directly or reimbursed by an external entity.
However, this disclosure requirement does not apply to:
- Any travel reimbursed, sponsored or paid for by a U.S. government agency, a U.S. higher education institution, a U.S. academic teaching hospital, medical center, or a U.S. research institute affiliated with a U.S. higher education institution; and
- Any travel reimbursement or payment of travel made by NJIT, a university college, department or unit, or travel covered by a sponsored program agreement managed through the Office of Research.
Ramp Up Phase-1, Phase-2 and Phase-3 Research Continuity and Recovery Operations Plan
For ramping up the phased research continuity and recovery operations, the following guidelines and protocols should be adopted for restoring research activities. The following protocols are subject to change based on the guidance and regulations from the federal, state, and local government agencies.
Phase-1: The institutionally approved Phase-1 research operations should continue with the required social distancing and safety protocols. As the phased research recovery plans ramp up carefully with a gradual and safe start of laboratory research activities, there will be an overlap of Phase-1 research recovery operations transitioning into the institutional Phase-2 operations. The current Phase-1 research recovery period is recommended until June 30, 2020 subject to the availability of appropriate PPE to enforce required safety protocols. The requested PPE supplies for Phase-1 operations have been ordered though the university but there may be delays in receiving the requested supplies depending on the availability in the market. Research labs are responsible for purchasing appropriate PPE supplies from their own funds in subsequent phases of research operations.
Phase-2: Each department should prepare a ramp up Phase-2 Research Continuity and Recovery (Phase-2 RCR) plan. The Phase-2 RCR plan should be approved by the college dean and then forwarded to the Office of Research for institutional approvals. As Phase-2 recovery would ramp up research activities to most funded research operations, the approvals to additional laboratory research operations would be approved by the department chair following the Phase-2 RCR plan subject to the availability of appropriate PPE to enforce required social distancing and safety protocols (consistent with federal, state and local guidelines).
Phase-3: Each department should prepare a ramp up Phase-3 Research Continuity and Recovery (Phase-3 RCR) plan. The Phase-3 RCR plan should be approved by the college dean and then forwarded to the Office of Research for institutional approvals. As Phase-3 recovery would ramp up research activities to most funded and unfunded research operations, the approvals to additional laboratory research operations would be approved by the department chair following the Phase-3 RCR plan subject to the availability of appropriate PPE to enforce required social distancing and safety protocols (consistent with federal, state and local guidelines).
Templates for recommended Phase-2 Research Operation (PRO-2) approval form, and departmental Phase-2 and Phase-3 Research Continuity and Receiver (RCR) plans are posted on the research website
NJIT Phased Research Recovery Plan
NJIT faculty, staff, and students at research facilities must follow the specific social distancing and safety protocols including the use of personnel protective equipment (PPE) as required by the institutional, state and federal guidelines in the respective phase of the research continuity plan. State and national information regarding current conditions can be found at:
- New Jersey’s COVID-19 information hub: https://covid19.nj.gov/index.html
- White House Plan for Opening up America Again: https://www.whitehouse.gov/wp-content/uploads/2020/04/Guidelines-for-Opening-Up-America-Again.pdf
- CDC guidelines on “Symptoms of Coronavirus”: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html
- CDC guidelines on “Use of Cloth Face Coverings to Help Slow the Spread of COVID-19”: https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/diy-cloth-face-coverings.html
The following guidelines should be adapted with each respective phase for the recovery of research operations.
Recovery Phase-0: All non-essential research operations halted. Essential research operations follow strictest social distancing and safety protocols with only essential staff.
- Safety within laboratories must be rigorously maintained with adequate access to PPE and other safety related supplies. Labs will not be authorized for access unless adequate safety supplies are identified as being available. PIs must identify by name the people that will be considered essential personnel (including replacements/backups). During this time all essential research operations (ERO) must be approved by chair, dean, and the senior vice provost for research through the emergency research continuity plan process currently in place.
- Research involving human subjects that requires face-to-face interaction with human subjects is halted.
- Research that can be conducted remotely should be continued to the extent possible.
Recovery Phase-1: Minimal research operations approved through chairs, deans and senior vice provost for research to pursue time-sensitive priority research such as projects related to COVID-19 response; approved Essential Research Operation (ERO) plans in Phase-0; long-term research experiments with cell-lines, animals, and human subjects that were already underway before Phase-0; grants and contracts expiring within six months; submission of proposals in response to special solicitations (Requests for Proposals); and projects involving students with graduation requirements.
- Requests for projects considered time-sensitive should be directed to departmental chairs. The dean and senior vice provost for research will provide guidance as needed.
- All research operations at NJIT facilities in this phase must follow the highest possible level of social distancing implemented.
- Research that can be conducted remotely should be continued to the extent possible.
- As on-campus operations are limited following the state and institutional safety regulations, visiting access to on-campus facilities is restricted.
- New applications for visiting scholars for research are on hold until NJIT enters the “new normal” phase of recovery.
Recovery Phase-2: Most research operations, whether sponsored through external grants and contracts or internally funded, may be restarted through the approval of department chairs using significant social distancing and safety protocols with restrictions on the number of researchers and staff present in laboratories at one time.
- The Phase-2 restart may require developing flexible work schedules, plan for supply chain issues, and prepare core and fabrication facilities in advance of need. To ensure social distancing requirements and to reduce density of research personnel in university research spaces, the lab directors should consider permitting flexible lab access schedules, work shifts or staggered workdays, and extended facilities support to enable more round-the-clock operation of research facilities. Under no circumstances should safety be sacrificed due to lack of adequate supplies, type, and quality of PPE.
- Research that can be conducted completely remotely or in addition to the on-campus operations should continue to be conducted in that manner.
- As on-campus operations are limited following the state and institutional safety regulations, visiting access to on-campus facilities is restricted.
- New applications for visiting scholars for research are on hold until NJIT enters the “new normal” phase of recovery.
Recovery Phase-3: Most research operations on funded and unfunded projects along with research required for future proposal submissions are restored with minimal social distancing and personnel safety protocols.
- Group meetings and research presentations with faculty, staff and students should be restricted and kept to a minimal size protecting any vulnerable participants. If possible, these meetings should continue to be held online until we reach a state of full recovery.
- Other laboratory safety protocols must be strictly followed.
- Research that can be conducted completely remotely or in addition to the on-campus operations should continue to be conducted in that manner.
- New applications for visiting scholars for research are on hold until NJIT enters the “new normal” phase of recovery.
Full Recovery: All research operations are restored fully with no specific social distancing requirements. However, all laboratory and personnel safety protocols must be strictly followed.
This document refers to research conducted on the NJIT campus in Newark, NJ, including the physical campus and activities that have direct contact with individuals (human subjects) anywhere. Satellite locations, such as the Big Bear Solar Observatory in California, must follow a similar phased approach informed by local conditions.
NJIT Research Continuity Plan: Phase-0
Updated March 26, 2020
Due to rapidly growing COVID-19 Pandemic, Governor Murphy has issued stay-at-home orders effective 9.00 PM, March 21, 2020.
All non-essential research operations in NJIT research laboratories and facilities are halted temporarily until further notice for the safety of the community and to be in compliance with the state order and associated travel restrictions. Limited continuation of laboratory research is only permitted for essential research operations but must follow the strongest safety protocols including the social distancing while working in the lab.
Essential research operations that are critical to maintenance and monitoring of research facility, animal care (with approved contingency plan) or exceptional experiments for which termination will lead to the irreversible loss of data must be approved at the institutional level (https://research.njit.edu/research-continuity-plan)
Students and post-docs must not be asked or expected to travel to campus for any non-essential research activity for their safety and to be in compliance with state and institutional regulations with the stay at home order.
As requested earlier, the checklist (posted on the research website (https://research.njit.edu/research-continuity-plan) should be followed to shut-down research laboratory operations.
All research activities that can be pursued remotely should be continued.
We hope that this period of unprecedented disruption will be over shortly. Until then please take every precaution to be safe and healthy.
Research Administration and Compliance
The Office of Research will continue to provide assistance on proposal submissions, pre-award and post-award grant management, research compliance and operational protocols to the best of our abilities. It is expected that Streamlyne will remain operational for proposal submissions and the following email addresses will be monitored regularly:
- Pre-Award inquiries: srard@njit.edu
- Post-Award financial management: gca@njit.edu
- Institutional Review Board: irb@njit.edu
- Institutional Biosafety Committee: ibc@njit.edu
Updates and university-wide resources in response to COVID-19 outbreaks are posted on the NJIT website https://www.njit.edu/coronavirus
If you have any questions related to research, please contact the Office of Research.
Coronavirus (COVID-19) Information on Sponsored Research Grants and Contracts
(Updated May 3, 2020)
Guidance on Financial Management of Grants and Contracts
The Office of Management and Budget issued a memorandum on 19 March 2020 (OMB 20-17 https://www.whitehouse.gov/wp-content/uploads/2020/03/M-20-17.pdf) providing guidance on issues related to grant management during the COVID-19 disruption. This memorandum provides short term relief for administrative, financial management, and audit requirements under 2 CFR Part 200, Uniform Administrative Requirements, Cost principles and Audit Requirements for Federal Awards, for the management of grants and contracts from all federal and non-federal sources under the COVID-19 public health emergency without compromising federal financial assistance accountability requirements.
Funding agencies such as NSF and NIH are following the OMB guidance with respect to grant management during this disruption to university business and research. The OMB Memorandum M-20-17 with the important information on the financial management of the research grants and contracts is posted on the research website https://research.njit.edu/research-continuity-plan. Links to current notifications from federal agencies are provided below. Principal investigators should check with the websites of their specific funding agencies for more information.
COVID-19 Information for NSF applicants and award recipients FAQ is regularly updated on the website https://www.nsf.gov/bfa/dias/policy/covid19/covid19faqs_dcl.pdf. COVID-19 Information for NIH applicants and recipients of NIH funding is regularly updated on the website https://grants.nih.gov/policy/natural-disasters/corona-virus.htm. A multiple Funding Agencies Research Impact Guidance Matrix by the Council of Government Relationships is posted on the website COGR's Federal Agency Guidance Matrix (XLS)
Coronavirus (COVID-19) Information on Sponsored Research Impact
Updated May 17, 2020
The Office of Research will continue to compile links for agency-specific guidance. The updates will be included in forthcoming Office of Research Newsletters and also posted on website https://research.njit.edu/.
Council on Government Relationships Resources on COVID-19's Impact to Federal Awards
- COGR Resource Information Institutional and Agency Responses to COVID-19 and Additional Resources (Updated Regularly)
- COGR's Federal Agency Guidance Matrix (XLS) (Updated) (Revised May 14, 2020)
- FAQ Addendum #1: NIH Specific FAQs (Updated) (Revised June 12, 2020)
- FAQ Addendum #2: Costing and Financial Compliance FAQs (Updated) (Revised May 1, 2020)
- FAQ Addendum #3: Research Ethics and Compliance Human Subjects FAQ (Version 1.0) (Revised May 4, 2020)
- FAQ Addendum #4: Contracts and Grants Administration FAQs (Version 1.0) (Revised May 8, 2020)
- FAQs Regarding COVID-19's Impact to Federal Awards (V.2.2) (Revised April 8, 2020)
- Multi Association Request to OMB on Expansion of M-20-11 for Administrative Relief (Revised March 18, 2020)
Office of Management and Budget
- M-20-20: Repurposing Existing Federal Financial Assistance Programs and Awards to Support the Emergency Response to the Novel Coronavirus (COVID-19) (April 9, 2020)
- M-20-18: Managing Federal Contract Performance Issues Associated with the Novel Coronavirus (COVID-19) (March 20,2020)
- OMB M-20-17: Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations (March 19, 2020)
- M-20-11: Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) (March 9, 2020)
National Institutes of Health (NIH)
Information on research impact:
- https://www.nih.gov/health-information/coronavirus
- https://grants.nih.gov/grants/natural_disasters/corona-virus.htm
On grant management:
- https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-083.html
- https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-082.html (Application deadlines)
- https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-091.html (Late application policy)
- Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients
- FAQ – COVID-19 Flexibilities for Applicants and Recipients
- Extramural Response to Natural Disasters and Other Emergencies (continuously updated)
- General Frequently Asked Questions (FAQs) - Proposal Submission and Award Management Related to COVID-19 (NOT-OD-20-083)
- Guidance for NIH-funded Clinical Trials and Human Subjects Studies Affected by COVID-19 (NOT-OD-20-087)
- Flexibilities for Assured Institutions for Activities of Institutional Animal Care and Use Committees (IACUCs) Due to COVID-19 (NOT-OD-20-088)
- Guidance on Travel and Meetings Hosted by NIH
- OLAW Webinar: Pandemic Contingency Planning and Its Impact on Animal Care
- NIH Shifts Non-mission-critical Laboratory Operations to Minimal Maintenance Phase
- Research and Funding Opportunities
- NIH Message to Applicants and Recipients of NIH Funds on Flexibilities Needed for COVID-19 (video)
- National Library of Medicine Expands Access to COVID-19 Literature through PubMed Central
- Late Application Policy Due to Public Health Emergency for US Due To COVID-19 (NOT-OD-20-091)
- Updated on COVID-19 Flexibilities for the Research Community (video)
National Science Foundation (NSF)
- NSF Implementation of OMB Memorandum M-20-20 (April 10, 2020)
- Frequently Asked Questions (FAQs) regarding the NSF Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19) (NSF 20-052) (Updated 4/6/20)
- NSF Implementation of OMB Memorandum M-20-17 (Revised April 1, 2020)
- https://www.nsf.gov/bfa/dias/policy/covid19/
covid19faqs_proposerandawardee.pdf (Revised April 2, 2020) - Impact on Existing Deadline Dates
- FAQ About the Coronavirus Disease 2019 (COVID-19) for National Science Foundation (NSF) Proposers and Awardees
- Important Notice No. 146 - NSF Letter to Community Regarding COVID-19
- NSF Guidance for Major Facilities and Contracts Regarding COVID-19
- NSF Responses to Natural Disasters
- Coronavirus Information
- Frequently Asked Questions (FAQs) About the Coronavirus Disease 2019 (COVID-19) for National Science Foundation (NSF) Panelists
- NSF information concerning coronavirus disease 2019 (COVID-19)
- Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19)
- BIO-Wide Virtual Office Hours
NSF Research on Coronavirus (COVID-19)
- Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19) — RAPID
- Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19) — RAPID
- Dear Colleague Letter: Request for SBIR/STTR Phase I Proposals Addressing COVID-19
- NSF Supporting Research to Address Coronavirus Disease blog
US Department of Energy
- ARPA-E Actions Owing to the COVID-19 Public Health Emergency (April 3, 2020)
- Accommodating Interruptions from Coronavirus Disease 2019 (COVID-19)
- Department of Energy Letter Addressing Coronavirus (COVID-19)
- Coronavirus Hub
United States Army Medical Research Acquisition Activity (USAMRAA)
- USAMRAA’s Supplemental Guidance on Administrative Flexibilities for Grants and Cooperative Agreements in Response to COVID-19 Pandemic (3/25/20)
- USAMRAA Animal Research Guidance (3/19/20)
- FAQs on COVID-19's Impact to Human Subjects Research
Defense Advanced Research Projects Agency (DARPA)
- COVID-19 Guidance USD(R&E)
- Frequently Asked Question (FAQ) about COVID-19 (Coronavirus) for DARPA Performers (March 19)
Department of Defense (DOD)
- ALLOW EXEMPTIONS FOR DOD FINANCIAL ASSISTANCE RECIPIENTS AFFECTED BY THE LOSS OF OPERATIONAL CAPACITY AND INCREASED COSTS DUE TO THE
COVID-19 CRISIS - COVID-19 FAQs for Grant Applicants and Recipients (3/26/20)
- Frequently Asked Questions for DOD Research Proposers and Awardees Impacted by the Novel Coronavirus (COVID-19) (3/24/20)
National Air and Space Administration (NASA)
- NASA COVID -19 For Grantees
- NASA Implementation of OMB Memorandum M-20-17 (Undated)
- Grants and Research during the COVID-19 Epidemic (3/25/20)
- COVID-19 Impact to NASA SBIR/STTR Program
- Coronavirus Information
- Assistant Administrator for Procurement Message on Coronavirus
- Memorandum for NASA Contractor Community - Preserving Readiness of the Space Industrial Base and Mission Operational Readiness due to COVID-19
USDA - National Institute of Food and Agriculture
- NIFA-20-006 Implementation of OMB Memo M-20-17 (4/9/20)
- NIFA FAQS for Grantees (4/8/20)
- NIFA Deadline Extensions due to COVID-19 (3/18.20)
- FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic
- FAQs on 3D Printing of Medical Devices, Accessories, Components, and Parts During the COVID-19 Pandemic
- FDA - Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19 (3/26/20)
Department of Health and Human Services
- OHRP Issues Guidance for Application of the Human Subjects Protection Regulations to Actions Taken in Response to the COVID-19 Pandemic (4/9/20)
- Preparation for Potential COVID-19 Impact on Contract and Contractor Performance (3/14/20)
- Administration for Children and Families (ACF) Grantees and Recipients- Information Memorandum: IM-ACF-OA-2020-01 (3/31/20)
- ORI Operations Status during Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19)
Environmental Protection Agency
National Endowment for the Arts (NEA)
National Endowment for the Humanities (NEH)
NJIT is taking new measures to minimize the spread and protect the health and safety of our community during the COVID-19 outbreak.
Beginning March 18 and until further notice, access to all on-campus research facilities will be limited to essential personnel necessary to maintain the long-term viability of the laboratory, equipment and other applicable resources (such as animals). All directors of research labs, centers and facilities should immediately prepare to discontinue all non-essential on-campus research activities by March 18.
Directors of research facilities must submit an Essential Research Operation (ERO) plan (in the format posted on the research website). All EROs must be submitted to the appropriate department chair and college dean for approval by March 18. Deans should forward all approved EROs to the senior vice provost for research by email.
EROs must include the strongest social distancing protocols for all essential personnel in on-campus facilities at all times. Non-essential research activities must halt on-campus activity, but may continue remotely if possible.
The Office of Research will continue to operate with full functionality to the extent possible following the research continuity plan posted on the NJIT website.
Other latest updates on NJIT response to COVID-19 outbreak are posted at https://www.njit.edu/coronavirus
We greatly appreciate your cooperation in helping to keep our community safe during this challenging period of global crisis.
Research Expectations
All directors of research centers/laboratories and Principal Investigators (PIs) should immediately begin preparing for restricting on-campus research to activities only with minimal access to facilities for maintaining animals, unique reagents, and essential equipment and materials.
These restrictions will be disruptive to the scholarly activities and research productivity but are essential for the safety and health of everyone in the community. All researchers should plan to continue working on the grants and research projects remotely as much as possible and conduct meetings through WebEx and teleconferencing.
All research work involving human subjects must follow the social distancing protocols and suspend any in-person interactions minimizing the study-visits to absolutely essential needs. All changes to the research protocols still need to be reviewed and approved by the IRB except for changes necessary to eliminate immediate apparent hazards including those based on the risk of exposure to COVID-19. Changes implemented to eliminate immediate apparent hazards should be promptly reported to the appropriate IRB.
We will work together to minimize the potential disruptions and difficulties caused by the restrictions with on-campus activities and follow up with federal and other funding agencies as needed on the appropriate responses related to grant management and expectations.
Research Lab Guidelines
The following guidelines should be strictly followed with immediate effect:
- Access to research laboratories should be limited to only essential personnel. If there are any individual necessary to be in the lab, social distancing protocols must be fully observed. Researchers who can work remotely must do so to continue research work to the extent possible.
- PI's should immediately identify essential research experiments that are at a critical phase, meaning that abandoning them would cause a major or irreversible loss in project viability. This high priority work should be a very limited set of the current laboratory bench-based experimentation.
- PI's should also identify experiments that can be ramped down, curtailed or delayed, and accomplish that process immediately.
- No new lines of research or experiments should be initiated at this time that require active and extensive use of lab resources in person.
- Disinfection of common laboratory areas and touch points (e.g., doorknobs, sink handles, freezer doors, telephones) with 70% ethanol should occur at least twice daily.
- Directors of research centers, laboratories and resources must develop appropriate plans to shut down equipment following due processes in case of university closure due to the severity of the COVID-19 outbreak. All PIs must also develop plans for maintaining laboratory viability (e.g. liquid nitrogen tank filling, animal support, maintaining shared computational equipment). Notify your departmental administrator as soon as possible about any issues related to laboratory facilities.
- External visitors should not be allowed in labs at this time.
- Make sure you have access to contact information for your students, postdocs, and staff, and review contingency plans and emergency procedures within your group.
Links to Agency-Specific Information
The following federal and agency guidelines should be reviewed to prepare plans to manage ongoing research grant activities.
Council on Governmental Relations
- COGR FAQs on COVID-19’s Impact on Federal Awards -Version 1 (March 12)
- Institutional and Agency Responses to COVID-19 and Additional Resources (March 10)
Office of Management and Budget
Department of Energy (3/12/20)
National Institutes of Health (3/12/20)
- Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19
- FAQs on COVID-19 Flexibilities for Applicants and Recipients
- NIH LATE APPLICATION POLICY Due to Public Health Emergency for the United States for 2019 Novel Coronavirus (COVID-19)
- General Frequently Asked Questions (FAQs) - Proposal Submission and Award Management Related to COVID-19
- NIH Guidance on Travel and Meetings Hosted by NIH
- NIH Extramural Response to Natural Disasters and Other Emergencies
National Science Foundation (3/12/20):
- Coronavirus Information
- Frequently Asked Questions (FAQs) About the Coronavirus Disease 2019 (COVID-19) for National Science Foundation (NSF) Proposers and Awardees
- Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19)
- NSF Guidance for Major Facilities and Contracts Regarding COVID-19
National Aeronautics and Space Administration (3/10/20)
Research Administration and Compliance
The Office of Research will continue to provide assistance on proposal submissions, pre-award and post-award grant management, research compliance and operational protocols to the best of our abilities. It is expected that Streamlyne will remain operational for proposal submissions and the following email addresses will be monitored regularly:
- Pre-Award inquiries: srard@njit.edu
- Post-Award financial management: gca@njit.edu
- Institutional Review Board: irb@njit.edu
- Institutional Biosafety Committee: ibc@njit.edu
All other research-related inquiries during an emergency should be submitted via https://research.njit.edu/researchtechnology-inquiry
Updates and university-wide resources in response to COVID-19 outbreaks are posted on the NJIT website https://www.njit.edu/coronavirus
If you have any questions related to research, please contact the Office of Research.
Atam P. Dhawan
Senior Vice Provost for Research
dhawan@njit.edu
We assist faculty to:
- Identify key faculty awards
- Review qualifications and requirements
- Engage all key stakeholders and collaboratively work to develop nomination packages
- Assist nominees and endorsers with drafting and editing reference letters
- Provide submission support
- Follow-up with awarding agency
Be Award-ready:
- Maintain an up-to-date CV
- Keep professional society memberships current
- Volunteer with professional societies and mentor students
- Be alert to emails about award opportunities
- Plan ahead (3-5 years) and develop your profile
About this initiative
Faculty awards and recognition are an important metric of the university’s performance. The goal of providing institutional support to applicants is to streamline the application process and increase the efficacy and impact of applications to prestigious awards and fellowships.
The awards pipeline is continuously in development. Deans, chairs and other faculty members are encouraged to put forward nominations for fellowships and other prestigious awards.
Please allow at least 6 weeks lead time on nominations. Package requirements and deadlines vary. Some deadlines are rolling with nominations accepted throughout the year. Interested deans, chairs and individual faculty should contact Dr. Shivon Boodhoo for help with nominations, general questions, and in-depth assistance with package preparation
General Streamlyne Content
Institutional Review Board (IRB)
- IRB - Intro to Streamlyne for IRB
- IRB - Research Modification Application
- IRB - Approving an IRB Submission for Research Team Members
Conflict of Interest (COI)
- COI - COI Support for Faculty
Proposal Development and Submission
♦ How to Input Proposal Budget
♦ How to Add a Sub-Award Budget
♦ How to Upload Proposal Attachments
♦ How to Search for a Proposal That Is In Route
♦ How to Search for an Opportunity ID
♦ Difference Between "Prime Sponsor Code" and "Sponsor Code"
♦ How to Select an RR Budget, RR Sub-Award Or Modular Budget
♦ How to Add a Student/Summary
♦ How to Add Other Organizations
♦ Participant Support Categories
♦ Supplies Specific Category Materials
♦ How to Create a Modular Budget